Search
Search Constraints
You searched for: Author/Creator Desprez, BertrandLimit your search
- Desprez, Bertrand [remove] 14
- Toxicology -- Periodicals 13
- 615.9 8
- 363.179 5
- Poisons -- Physiological effect -- Periodicals 4
- Toxicity testing -- In vitro -- Periodicals 4
- Skin sensitization -- LLNA -- human reference data -- non-animal -- test methods -- in vitro -- in chemico -- database -- defined approach -- testing strategy 2
- Skin sensitization -- defined approaches -- hazard assessment -- potency assessment -- integrated testing strategy -- human reference data -- LLNA reference data -- new approach methodologies -- adverse outcome pathway 2
- 363.192094 1
- ADME absorption, distribution, metabolism, elimination -- AOP adverse outcome pathway -- EFSA European Food and Safety Agency -- EURL ECVAM European Union Reference Laboratory for Alternatives to Animal Testing -- FDA US Food and Drug Administration -- IATA Integrated Approaches to Testing and Assessment -- LRSS Long Range Science Strategy -- MoA mode of action -- NOTEL no observed transcriptomic adverse effect level -- OECD Organisation for Economic Cooperation and Development -- PBPK Physiologically based pharmacokinetics -- PoD point of departure -- SEURAT-1 Safety Evaluation Ultimately Replacing Animal Test programme -- QIVIVE quantitative in vitro-in vivo extrapolation -- US EPA US Environmental Protection Agency -- TD toxicodynamics -- TK toxicokinetics -- TTC threshold of toxicological concern -- iTTC internal threshold of toxicological concern -- TRV toxicological reference value 1
- AO(P)(s) adverse outcome (pathway(s)) -- CE Cosmetics Europe -- ICCR International Cooperation on Cosmetics Regulation -- KE(s)(R)(s) key event(s) (relationship(s)) -- LRSS Long Range Science Strategy -- MIE molecular initiating event -- MIP-DILI Mechanism Based Integrated Systems for the Prediction of Drug Induced Liver Injury -- MoA(s) mode(s)-of-action -- PBBK physiologically-based biokinetics -- QIVIVE quantitative in vitro-in vivo extrapolation -- QSAR(s) quantitative structure-activity relationship(s) -- RDT repeated dose toxicity -- SEURAT-1 Safety Evaluation Ultimately Replacing Animal Testing -- TTC threshold of toxicological concern 1